Mrs. Anita Kaminski, Chairwoman of the ICA Munich Friends, and her team organized a very successful fundraising event for the ICA which took place on Sunday, May 18, 2014.
This year, the Friends Group decided to support the Israel Genetics Consortium, with the generous assistance of the 120 guests who participated in the event. Breast cancer incidence rates in Israel are among the highest in the world, partly due to the country's high prevalence of BRCA 1/2 gene mutations. Consequently, Israel may be regarded as a "natural genetics laboratory", affording unique opportunities for breast cancer prevention, treatment and research.
Professor Efrat Levy-Lahad, who honored the Friends with her presence at the gala, heads this Consortium, which operates under the auspices of the ICA and engages in nationwide collaborative cancer genetics research. The Consortium conducts joint and multi-center research on the genetics of breast and ovarian cancer in Israel. Thanks to the Consortium activities, several studies with universal implications have already appeared in leading international scientific publications.
The importance of the Genetics Consortium was also underlined by Professor Wolfgang Eiermann, an internationally recognized expert in the treatment of breast cancer and in the field of gynecologic oncology. He also established a nationally and internationally recognized center for gynecologic oncology alongside the general practice of obstetrics and gynecology.
The other highlights of the evening were a raffle, an auction and a musical performance, which was very much appreciated by the guests.
Click here to read the article which was published in the Jüdische Allgemeine on June 15, 2014 (in German).